Ensysce Biosciences
www.ensysce.comEnsysce Biosciences, Inc. (NASDAQ: ENSC) is a clinical-stage biotech company developing a new class of prescription drugs that will provide patients and prescribers safer options for the use of potent prescription drugs, reducing abuse and preventing overdoses.
Read more
Ensysce Biosciences, Inc. (NASDAQ: ENSC) is a clinical-stage biotech company developing a new class of prescription drugs that will provide patients and prescribers safer options for the use of potent prescription drugs, reducing abuse and preventing overdoses.
Read more
Country
State
Louisiana
Industry
Employees
11-50
Founded
2008
Estimated Revenue
$1,000,000 to $5,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Chief Commercial Officer
Email ****** @****.comPhone (***) ****-****Chief Operating Officer
Email ****** @****.comPhone (***) ****-****Chief Development Officer
Email ****** @****.comPhone (***) ****-****
Technologies
(19)
Reach decision makers at Ensysce Biosciences
Free credits every month!
Ensysce Biosciences FAQ
United States
Biotechnology Research
